Biosimilars and Biologics

As the demand of Biosimilars is ever increasing in the pharmaceutical market, it is very important to check them properly before releasing it to the mass. That is why there is a stepwise approach towards clinical trials of Biosimilars. It has various levels such as Extensive Molecular characterization Program, Pre-Clinical, Phase 1, Phase 3, Phase 4 and so on.

• Aspects of Genotoxicity Tests
• Biosimilars Clinical Studies
• Toxicological Studies
• Transgenic Animals